Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 17 of 47
  1. Dextromethorphan HBr

    Galera Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial
  2. Digoxin

    PUMA BIOTECHNOLOGY, INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  3. Digoxin

    The First People's Hospital of Lianyungang

    Healthy

    phase 1 small molecule completed

    1 trial
  4. Digoxin

    Hospital Authority, Hong Kong

    Healthy

    phase 1 small molecule completed

    1 trial
  5. Digoxin vs Digoxin + BEM/RZR vs Digoxin + 2h BEM/RZR

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial
  6. Divalproex Sodium

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    4 trials
  7. Donepezil

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  8. Donepezil Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  9. Doxycycline Monohydrate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  10. Drospirenone/Ethinyl Estradiol (Gianvi®)

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  11. Drug: AT-527 + rosuvastatin

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial
  12. Dupilumab (SAR231893)

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  13. Dupilumab (SAR231893)

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  14. E0302 SR1

    Eisai Co.,

    Healthy Subjects

    phase 1 small molecule completed

    1 trial
  15. E6007

    Eisai Co.,

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  16. EDG-15400

    Edgewise Therapeutics

    Healthy Adults

    phase 1 small molecule active

    1 trial
  17. EDG-5506

    Edgewise Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  18. EDG-5506 Tablet

    Edgewise Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  19. EDG-7500

    Edgewise Therapeutics

    Healthy Subjects

    phase 1 small molecule completed

    1 trial
  20. EDG-7500

    Edgewise Therapeutics

    Healthy Adult Participants

    phase 1 small molecule active

    1 trial
  21. EDP-788

    ENANTA PHARMACEUTICALS INC

    Healthy

    phase 1 small molecule terminated

    1 trial
  22. EP395-006

    Lacuna Pharma Pty Ltd

    Healthy volunteers [targeted indication: chronic obstructive pulmonary disease (COPD)]

    phase 1 other active

    1 trial
  23. ESAT6-CFP10

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 mab completed

    1 trial
  24. ESN364

    Astellas Pharma Inc

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.